 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | ASP6981 / Astellas
Trial completion: A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia (clinicaltrials.gov) - Jul 17, 2018
P1, N=32, Completed, Sponsor: Astellas Pharma Global Development, Inc.
Recruiting --> Completed
- ASP6981 / Astellas
Enrollment open, Trial initiation date: A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia (clinicaltrials.gov) - Feb 5, 2018
P1, N=32, Recruiting, Sponsor: Astellas Pharma Global Development, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Jan 2018 --> Jan 2018
- | ASP6981 / Astellas
New P1 trial: A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia (clinicaltrials.gov) - Nov 29, 2017
P1, N=32, Not yet recruiting, Sponsor: Astellas Pharma Global Development, Inc.